RIP and miRNA pull-down assays revealed that GAS5 was enriched in beads containing ago2 and can be pull down by biotin-labeled miR-217 in cisplatin-resistant NSCLC cells. The gene discussed is GAS5; the disease is non-small cell lung carcinoma.